Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands [0.03%]
缓释型注意缺陷多动障碍药物在荷兰的可用性降低了一岁以下45岁儿童、青少年和成人患者的用药中断率
Els van den Ban,Patrick C Souverein,Hanna Swaab et al.
Els van den Ban et al.
Treatment options for ADHD in the Netherlands have increased with the introduction of the extended-release formulations of methylphenidate (MPH ER, Concerta(®)) in 2003 and atomoxetine (ATX, Strattera(®)) in 2005, but data on the effect o...
Klaus W Lange,Susanne Reichl,Katharina M Lange et al.
Klaus W Lange et al.
The contemporary concept of attention deficit hyperactivity disorder (ADHD) as defined in the DSM-IV-TR (American Psychiatric Association 2000) is relatively new. Excessive hyperactive, inattentive, and impulsive children have been describe...
Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings [0.03%]
开放式阿托莫西汀治疗注意缺陷多动障碍患者期间的青少年患者的自尊心：罗斯滕伯格自尊量表的心理测量学评价及临床结果
Ralf W Dittmann,Peter M Wehmeier,Alexander Schacht et al.
Ralf W Dittmann et al.
To report on (1) psychometric properties of the Rosenberg Self-Esteem Scale (SES) studied in adolescents with ADHD, (2) correlations of SES with ADHD scale scores, and (3) change in patient-reported self-esteem with atomoxetine treatment. A...
Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder [0.03%]
关于注意缺陷多动障碍及对立违抗障碍共病与阿托莫西汀血药浓度、治疗疗效和耐受性的关系研究
Philip Hazell,Katja Becker,Eija A Nikkanen et al.
Philip Hazell et al.
The purpose of this study was to examine whether atomoxetine plasma concentration predicts attention-deficit/hyperactivity disorder (ADHD) or oppositional defiant disorder (ODD) response. This post-hoc analysis assessed the relationship bet...
Randomized Controlled Trial
Attention deficit and hyperactivity disorders. 2009 Dec;1(2):201-10. DOI:10.1007/s12402-009-0012-4 2009